C07D 495/14
Ortho-condensed systems
C07D495/14 (Ortho-condensed systems) appears on 1,012 US grants and 1,109 published applications in this corpus.
Search patents in C07D- Granted patents
- 1,012
- Published applications
- 1,109
- Assignees
- 531
- Inventors
- 3,407
- Latest grant
- 25 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 4 | 0 |
| 1977 | 1 | 0 |
| 1978 | 5 | 0 |
| 1979 | 4 | 0 |
| 1980 | 6 | 0 |
| 1981 | 5 | 0 |
| 1982 | 25 | 0 |
| 1983 | 17 | 0 |
| 1984 | 6 | 0 |
| 1985 | 6 | 0 |
| 1986 | 5 | 0 |
| 1987 | 12 | 0 |
| 1988 | 12 | 0 |
| 1989 | 16 | 0 |
| 1990 | 11 | 0 |
| 1991 | 11 | 0 |
| 1992 | 16 | 0 |
| 1993 | 6 | 0 |
| 1994 | 9 | 0 |
| 1995 | 23 | 0 |
| 1996 | 8 | 0 |
| 1997 | 24 | 0 |
| 1998 | 16 | 0 |
| 1999 | 9 | 0 |
| 2000 | 10 | 0 |
| 2001 | 13 | 1 |
| 2002 | 11 | 19 |
| 2003 | 16 | 21 |
| 2004 | 12 | 16 |
| 2005 | 15 | 19 |
| 2006 | 7 | 20 |
| 2007 | 14 | 26 |
| 2008 | 10 | 22 |
| 2009 | 9 | 29 |
| 2010 | 20 | 31 |
| 2011 | 23 | 40 |
| 2012 | 15 | 40 |
| 2013 | 30 | 40 |
| 2014 | 34 | 52 |
| 2015 | 46 | 60 |
| 2016 | 44 | 49 |
| 2017 | 51 | 45 |
| 2018 | 39 | 65 |
| 2019 | 49 | 62 |
| 2020 | 42 | 67 |
| 2021 | 44 | 73 |
| 2022 | 44 | 63 |
| 2023 | 44 | 65 |
| 2024 | 51 | 57 |
| 2025 | 36 | 76 |
| 2026 | 26 | 51 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Cyclic compounds and methods of using same25 Aug 2026US 12,715,876 B2Schrödinger, Inc.
- Protein degraders and uses thereof25 Aug 2026US 12,715,877 B2Kymera Therapeutics, Inc.
- p53 modulators and uses thereof28 Jul 2026US 12,692,273 B2The Regents of the University of California
- MK2 inhibitors and uses thereof30 Jun 2026US 12,668,598 B2Bristol-Myers Squibb Company
- Heterobifunctional compounds and methods of treating disease30 Jun 2026US 12,668,599 B2Halda Therapeutics OpCo, Inc.
- Heterobifunctional compounds and methods of treating disease8 Oct 2026US 2026/0308171 A1Halda Therapeutics OpCo, Inc.
- Compound for organic photoelectric element, organic photoelectric element, image sensor and electronic device comprising the same8 Oct 2026US 2026/0314261 A1Duk San Neolux Co., Ltd.
- Inhibitors of parg24 Sep 2026US 2026/0285875 A1858 Therapeutics, Inc.
- 1-thioxo-2,4-dihydrothieno[2,3-e] [1,2,4]triazolo[4,3-a]pyrimidin-5(1h)-one derivatives as allosteric inhibitors of the polo-like kinase 1 (plk1) polo box domain (pbd) for the treatment of cancer17 Sep 2026US 2026/0272934 A1The United States of America, as represented by the Secretary, Department of Health and Human Servic
- 3h-pyrazolo[4.3:f] quinoline-based compounds as sting antagonists17 Sep 2026US 2026/0274838 A1Purdue Research Foundation
Most cited
By later US patents
- Tricyclic fused thiophene derivatives as JAK inhibitors102US 9,181,271 B2Incyte Corporation · 2015
- Thienotriazolodiazepine compound and pharmaceutical use thereof84US 5,721,231 AYoshitomi Pharmaceutical Industries, Ltd. · 1998
- Derivatives of 1,2-dihydro-7-hydroxyquinolines containing fused rings84US 6,716,979 B2Molecular Probes, Inc. · 2004
- Fused heteroaryl derivatives77US 6,608,053 B2Imperial Cancer Research Technology, Ltd. · 2003
- Methods to induce targeted protein degradation through bifunctional molecules71US 9,694,084 B2Dana-Farber Cancer Institute, Inc. · 2017